This week, the Federal Trade Commission (FTC) announced that a company’s president and CEO must pay a $140 million judgment based on participation in a timeshare exit scheme. The FTC also took action that backed Chairman Ferguson’s prioritization of healthcare fraud with the establishment of a Healthcare Task Force in March. More on these stories after the jump.

The Federal Trade Commission (FTC) was especially active in the consumer protection space this past week, including announcing three separate enforcement actions based on earnings claims and three more for Made in USA claims. On the competition side, the FTC took action against noncompete agreements. These stories and more after the jump.

The FTC has been active across both consumer protection and competition spaces in the past two weeks. In the consumer protection space, the agency announced several proposed settlements with companies and individuals, resolving complaints of alleged deceptive marketing, consumer privacy violations, and false advertising. In the competition space, the FTC and DOJ’s Antitrust Division launched a joint public inquiry into the effectiveness of the updated HSR premerger notification form. Operationally, the FTC was also engaged on several fronts, including testifying before the Joint Economic Committee, submitting its FY 2027 budget request to Congress, and announcing its five-year strategic plan. These stories and more after the jump.

The Federal Trade Commission continued its active enforcement posture in late March 2026, with significant developments spanning healthcare, franchise regulation, competition, and consumer financial protection. The Commission distributed more than $10.9 million to consumers harmed by a credit repair pyramid scheme, while the FTC secured a record-breaking franchise settlement. Chairman Ferguson also launched a new Healthcare Task Force to coordinate agency-wide enforcement efforts in the healthcare sector. These stories and more after the jump.

The FTC has been busy sending money to consumers harmed by unfair or deceptive business acts or practices. The Commission has also announced a settlement with healthcare companies related to the cost of insulin drugs and released a recent report regarding it focus on privacy and cybersecurity. More on this news after the jump.

In this round of updates, we see updates to several FTC actions related to deceptive marketing as well as several administrative updates.  The FTC has named a deputy director of the bureau of competition and held several workshops on topics of data privacy and security. We also saw several Advance Notices of Proposed Rule Making (ANPRM). These stories and more after the jump.